| |
Journal of Neurochemistry, Vol. 96, No. 3. (2006), pp. 706-718.
|
| |
The Journal of Comparative Neurology, Vol. 492, No. 2. (2005), pp. 178-192.
|
| |
Toxicology and applied pharmacology (8 April 2009)
|
| |
J. Neurosci., Vol. 29, No. 10. (11 March 2009), pp. 3328-3336.
|
| |
Mol Pharmacol, Vol. 71, No. 6. (1 June 2007), pp. 1598-1609.
|
| |
Br J Pharmacol, Vol. 137, No. 8. (December 2002), pp. 1155-1162.
|
| |
Toxicol. Sci., Vol. 61, No. 1. (1 May 2001), pp. 100-106.
|
| |
J Pharmacol Exp Ther, Vol. 305, No. 1. (21 January 2003), pp. jpet.102.043166-218.
|
| |
Experimental neurology, Vol. 212, No. 2. (August 2008), pp. 522-531.
|
| |
The Journal of Pain, Vol. 7, No. 9. (September 2006), pp. 611-614.
|
| |
FASEB J. (18 July 2002), 02-0216fje.
|
| |
Clinical Science, Vol. 105 (2003), pp. 213-218.
|
| |
Journal of Molecular Neuroscience (July 2007), pp. 217-227.
|
| |
World Journal of Biological Psychiatry (October 2007)
|
| |
Fibromyalgia Frontiers, Vol. 13, No. 1. (2005)
|
| |
Free radical research (4 February 2009), pp. 1-9.
|
| |
|
| |
CRIPS, Vol. 7, No. 4. (2006)
|
| |
Journal of Neurochemistry, Vol. 101, No. 1. (April 2007), pp. 109-119.
|
| |
Neuropharmacology, Vol. 44, No. 5. (April 2003), pp. 624-632.
|
| |
Journal of Neuroscience Research, Vol. 75, No. 1. (2004), pp. 107-116.
|